These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36748224)

  • 1. Atherosclerotic Cardiovascular Disease in Diabetes Patients.
    Amelia R; Sari Wahyuni A; Yunanda Y; Wijaya H
    Curr Diabetes Rev; 2023; 19(8):e060223213457. PubMed ID: 36748224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Cardiovascular Complication Among Type 2 Diabetes Mellitus Patients in Medan, Indonesia. A Cross-sectional Study.
    Amelia R; Wijaya H; Rusdiana R; Widjaja SS
    Med Arch; 2022 Oct; 76(5):324-328. PubMed ID: 36545452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes associated residual atherosclerotic cardiovascular risk in statin-treated patients with prior atherosclerotic cardiovascular disease.
    Zhao Y; Xiang P; Coll B; López JAG; Wong ND
    J Diabetes Complications; 2021 Mar; 35(3):107767. PubMed ID: 33168394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a Nomogram Model to Identify Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus.
    Sun H; Men C; Deng H; Wang C; Li R; Sun Y; Yang H; Wu M; Zheng W; Zhan Y
    Discov Med; 2023 Dec; 35(179):1114-1122. PubMed ID: 38058077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age at diagnosis, diabetes duration and the risk of cardiovascular disease in patients with diabetes mellitus: a cross-sectional study.
    Yao X; Zhang J; Zhang X; Jiang T; Zhang Y; Dai F; Hu H; Zhang Q
    Front Endocrinol (Lausanne); 2023; 14():1131395. PubMed ID: 37223032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge of HbA1c and LDL-C treatment goals, subjective level of disease-related information and information needs in patients with atherosclerotic cardiovascular disease.
    Brockmeyer M; Wies E; Joerges J; Sommer J; Borgmann SO; Chernyak N; Lin Y; Parco C; Schulze V; Heinen Y; Kelm M; Icks A; Perings S; Wolff G
    Clin Cardiol; 2023 Feb; 46(2):223-231. PubMed ID: 36448416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes by atherosclerotic cardiovascular disease risk score and blood pressure level in high risk individuals with type 2 diabetes.
    Harris K; Muntner P; Woodward M; Jun M; Oshima M; Gong J; Harrap S; Menard J; Chalmers J
    J Hum Hypertens; 2023 Mar; 37(3):181-188. PubMed ID: 35184142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: a cohort-based cross-sectional study.
    Zibaeenejad F; Mohammadi SS; Sayadi M; Safari F; Zibaeenezhad MJ
    BMC Cardiovasc Disord; 2022 Apr; 22(1):162. PubMed ID: 35397522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between atherosclerotic cardiovascular disease and diabetic retinopathy in patients with type 2 diabetes mellitus.
    Li L; Gao J; Rao X; Liu X
    Medicine (Baltimore); 2024 May; 103(19):e38051. PubMed ID: 38728488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry.
    Fan W; Song Y; Inzucchi SE; Sperling L; Cannon CP; Arnold SV; Kosiborod M; Wong ND
    Diabetes Obes Metab; 2019 May; 21(5):1121-1127. PubMed ID: 30609214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan.
    Wake M; Oh A; Onishi Y; Guelfucci F; Shimasaki Y; Teramoto T
    Atherosclerosis; 2019 Mar; 282():19-28. PubMed ID: 30669019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients. Beyond LDL cholesterol and hypolipidemic treatment.
    Delialis D; Georgiopoulos G; Aivalioti E; Mavraganis G; Dimopoulou AM; Sianis A; Aggelidakis L; Patras R; Petropoulos I; Ioannou S; Syrigou R; Chatzidou S; Kanakakis I; Stellos K; Stamatelopoulos K
    Hellenic J Cardiol; 2022; 66():26-31. PubMed ID: 35667617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Elevated Cardiovascular Risks in Young Adults: A Cross-sectional Analysis of National Health and Nutrition Examination Surveys.
    Patel KK; Taksler GB; Hu B; Rothberg MB
    Ann Intern Med; 2017 Jun; 166(12):876-882. PubMed ID: 28505660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors.
    Whelton SP; McEvoy JW; Shaw L; Psaty BM; Lima JAC; Budoff M; Nasir K; Szklo M; Blumenthal RS; Blaha MJ
    JAMA Cardiol; 2020 Sep; 5(9):1011-1018. PubMed ID: 32936272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factor profiles in familial hypercholesterolemia patients with and without genetic mutation compared to a nationally representative sample of adults in a high-risk European country.
    Chlebus K; Zdrojewski T; Gruchała M; Gałąska R; Pajkowski M; Kocejko MR; Chmara M; Pencina MJ
    Am Heart J; 2019 Dec; 218():32-45. PubMed ID: 31706143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B With Cardiovascular Disease Occurrence in Adults: Korean Genome and Epidemiology Study.
    Yun SY; Rim JH; Kang H; Lee SG; Lim JB
    Ann Lab Med; 2023 May; 43(3):237-243. PubMed ID: 36544335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating longitudinal history of risk factors into atherosclerotic cardiovascular disease risk prediction using deep learning.
    Yu J; Yang X; Deng Y; Krefman AE; Pool LR; Zhao L; Mi X; Ning H; Wilkins J; Lloyd-Jones DM; Petito LC; Allen NB
    Sci Rep; 2024 Jan; 14(1):2554. PubMed ID: 38296982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal trends in atherosclerotic cardiovascular disease risk among U.S. adults. Analysis of the National Health and Nutrition Examination Survey, 1999-2018.
    Chobufo MD; Singla A; Rahman EU; Michos ED; Whelton PK; Balla S
    Eur J Prev Cardiol; 2022 Dec; 29(18):2289-2300. PubMed ID: 35919951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-Related Associations of Low-Density Lipoprotein Cholesterol and Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based Cohort Study.
    Jung HN; Kim MJ; Kim HS; Lee WJ; Min SH; Kim YJ; Jung CH
    J Am Heart Assoc; 2022 May; 11(9):e024637. PubMed ID: 35492003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal-weight visceral obesity promotes a higher 10-year atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus-a multicenter study in China.
    Zheng J; Hu Y; Xu H; Lei Y; Zhang J; Zheng Q; Li L; Tu W; Chen R; Guo Q; Zang X; You Q; Xu Z; Zhou Q; Wu X
    Cardiovasc Diabetol; 2023 Jun; 22(1):137. PubMed ID: 37308932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.